Summary
HCA Holdings, Inc. (HCA) reported strong financial performance for the nine months ended September 30, 2014, with revenues increasing by 7.6% to $27.28 billion compared to the same period in the prior year. Net income attributable to HCA Holdings, Inc. also saw a significant increase of 19.1%, reaching $1.35 billion, with diluted earnings per share rising to $2.98 from $2.44 in the prior year. This growth was driven by a combination of increased patient volumes, higher revenue per equivalent admission, and a reduction in the provision for doubtful accounts, likely benefiting from broader healthcare coverage expansion. Operationally, HCA saw improvements across key metrics, including a 2.1% increase in consolidated admissions and a 3.3% rise in consolidated equivalent admissions for the nine-month period. The company also experienced a notable decrease in uninsured admissions, attributing this to increased coverage through health insurance exchanges and Medicaid expansion programs. Despite significant legal claims and ongoing government investigations, HCA's liquidity remains robust, supported by strong operating cash flows and available credit facilities, enabling continued investment in capital expenditures and share repurchases.
Financial Highlights
46 data points| Revenue | $9.22B |
| Interest Expense | $427.00M |
| Net Income | $518.00M |
| EPS (Basic) | $1.20 |
| EPS (Diluted) | $1.16 |
| Shares Outstanding (Basic) | 432.62M |
| Shares Outstanding (Diluted) | 447.26M |
Key Highlights
- 1Revenue for the nine months ended September 30, 2014, increased by 7.6% to $27.28 billion compared to the prior year.
- 2Net income attributable to HCA Holdings, Inc. grew by 19.1% to $1.35 billion for the nine months ended September 30, 2014.
- 3Diluted earnings per share increased to $2.98 for the nine months ended September 30, 2014, up from $2.44 in the prior year.
- 4Consolidated admissions increased by 2.1% and equivalent admissions by 3.3% for the nine-month period, indicating higher patient volumes.
- 5A significant decrease in the provision for doubtful accounts was observed, likely due to improved healthcare coverage among patients.
- 6The company repurchased $750 million of its common stock during the first nine months of 2014.
- 7Cash flows from operating activities increased by $367 million to $2.82 billion for the nine months ended September 30, 2014.